Navigation Links
ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008
Date:4/11/2008

DENVER, and GOLDEN, Colo., April 11 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today its continued support for the American Association for Cancer Research (AACR) and will exhibit at the annual meeting taking place at the San Diego Convention Center, April 12 - 16, 2008.

"The AACR meeting is a highlight of the year for ABR as we devote a significant portion of our corporate resources to supporting biological research in this critically important area," said Ken Wilczek, President of ABR-Affinity BioReagents. ABR's product portfolio includes over 3,000 quality guaranteed cancer biology antibodies. "Attendance at this meeting affords us the opportunity to enhance our understanding of what today's researchers are focusing on in terms of potential targets and timelines. Each year there are an increasing number of significant developments contributing to extraordinary advances in cancer-related disease research. This is just a great forum in which to interact on a personal level with a cross section of the top life science researchers in the U.S. and around the world. We derive much of our strategic direction from this type of input," finished Mr. Wilczek.

ABR-Affinity BioReagents will be launching 7,500 new products at the meeting across a selection of research areas including: Apoptosis; Cancer Biology; Heat Shock Protein; Ion Transport/Regulation; Neurobiology; Signal Transduction; Transcription Regulation; and Vision.

ABR will be located at booth #820 at next week's meeting in San Diego.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry-research antibodies that are 100% quality guaranteed or your money back-with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.


'/>"/>
SOURCE ABR-Affinity BioReagents
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies
2. ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007
3. ABR-Affinity BioReagents Finalizes Agreement for Distribution of Osenses Antibodies in the U.S., Canada and Europe
4. ABR-Affinity BioReagents to Exhibit at the Society for Biomolecular Sciences in St. Louis, April 6 - 10, 2008
5. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
6. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. Angiotech to participate in UBS Global Life Sciences Conference
9. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
10. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
11. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... ... 2017 , ... At its national board meeting in North ... the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology and ... ARCS Alumni Hall of Fame . ASTER Labs is a technology development ...
(Date:10/11/2017)... ... ... is a basic first aid supply for any work environment, but most personal eye wash ... if a dangerous substance enters both eyes? It’s one less decision, and likely quicker response ... piece. , “Whether its dirt and debris, or an acid or alkali, getting anything in ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
Breaking Biology News(10 mins):